This webinar will discuss the FDA requirements and guidelines for investigating Out-of-trend (OOT) results in the pharmaceutical laboratory. It will also cover FDA-compliant documentation of OOT, failure investigations, root causes, and CAPA.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
Kelly Thomas Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
FDA's Technology Modernization Action Plan (TMAP) And Impac…
Nailing the Candidate Experience, Attracting Talent
Stop Letting that Difficult Person Ruin your Day - Effectiv…
Developing and Implementing Inclusive Leadership Strategies
Improving Organizational Performance through Enhanced Emplo…
Supervising a Human Error Free Environment: You can do a Lo…
Creative Leadership through Emotional (EQ) and Humor (HQ) I…
New Announcement! DHS Terminates The I-9 Form Remote Option…
Faster Payments in Today's World - Details on the Different…
Payroll Management - Tips To Make Payroll Processing Easier…
FDA's new Cosmetic labeling requirements
Why EBITDA Doesn't Spell Cash Flow and What Does
Ultimate Persuasion Strategies! - Secret Influence Tools & …
Introduction to Design of Experiments
Small Business Management Made Simple: Tools, Tips & Techni…
Design Control for Medical Devices and Combination Products
I-9 Audits: Strengthening Your Immigration Compliance Strat…
Employee Business Expense Reimbursement (2023 Updates)
Project Management for administrative professionals
Accounting For Non Accountants : Debit, Credits And Financi…
Healthcare Data Analytics: Methods of matching scarce resou…
Establishing Appropriate Quality Metrics and Key Performanc…
Managing Toxic & Other Employees Who have Attitude Issues
Confessions Of A Cia Spy - The Art Of Human Hacking
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Onboarding is NOT Orientation - How to Improve the New Empl…
The Importance Of Documentation For Supervisors And Managers